EXR

0.00%

16.5¢ elixir energy limited

Hi Garfus and welcome back, What a wonderful post. You are spot...

First 2192 Last

Share
Profile

Follow
tui

6,115 Posts.

1502

21/10/22

08:50

Post #: 64312933
Share

Originally posted by Garfus ↑

Hi all, so first things first, I have been gradually buying back in thought it would be at 15c+ but happily scooping up anything I can at 14.5. Was fortunate enough to invest half of what I sold in EXR in QXR when I saw Steve Promnitz had been appointed so enjoyed that pump from 3.5 to 9c...

Anyway, I digress, the last couple of months I have reexamined why I invested in EXR in the first instance and what I think the next 6 months or so could bring.

When doing my initial research I was amazed to find that NY went to the same Uni and studied the same degree as I did, exactly 10 years apart (83-87 as opposed to 93-97). He also comes from Scottish Presbyterian stock like myself, which sounds trivial but to me it meant 3 things:

1. He was unlikely to ever resort to hyperbole

2. Any money raised would be spent wisely

3. He would work tirelessly to maximise the potential of the business

The conservative background is, of course, a double edged sword and I am frequently frustrated that we haven't got our remarkable 3 fold story out there.

Second guessing NY what I believe will be the sequence of events he and the team are working for is:

1. We formalize our relationship with SoftBank either just before or just after Xmas. This will bring alot of foreign interest and will freshen up the register. Depending on the nature of the JV I see us forming an SP base between 36-50c depending on how many bail when we hit the CR price.

2. We have something definitive on the commerciality or otherwise or the gas flow by mid to late Feb. Provided this proves successful a dollar sign goes in front of the SP within a matter of months.

3. Just as the above is starting to calm down we have some real meat on the bones in QLD.

There is no doubt the past year has been incredibly frustrating for all SH a frustration clearly shared by NY as reflected in his body language in the last preso, BUT I did note a clear change of language in the last update and whilst my faith did waiver I am really bullish about the next 6-12 months.

Nothing has changed, whilst it seems fanciful atm there really is no reason why we can't be at anything from $5 to $10 by mid 2024, depending on whether the hydrogen business remains part of the core or not.

Anyway, very glad to be back in the fold, will continue to buy til I get to the 2.5million mark.

As ever, GLTAH and all very much IMO.

Expand

Hi Garfus and welcome back,
What a wonderful post. You are spot on regarding Neil. And EXR’s future. I have known Neil for many years and your points above are so true.
We are in very good hands.
Best
tui

Ps. It’s the waiting that is the hardest part!

EXR Price at posting: 14.5¢ Sentiment: Buy Disclosure: Held
29 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 1,921 more messages in this thread...

First 2192 Last

Add EXR (ASX) to my watchlist

(20min delay)
Last 16.5¢		Change 0.000(0.00%)		Mkt cap ! $197.4M

Open	High	Low	Value	Volume
17.0¢	17.0¢	16.0¢	$254.5K	1.534M

Buyers (Bids)

No.	Vol.	Price($)
3	316607	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	106270	7

View Market Depth

No.	Vol.	Price($)
3	316607	0.165
8	231589	0.160
4	241166	0.155
13	554770	0.150
7	539692	0.145

Price($)	Vol.	No.
0.170	100388	6
0.175	353986	7
0.180	690855	13
0.185	68701	3
0.190	199892	9

Last trade - 16.10pm 04/10/2024 (20 minute delay)

EXR (ASX) Chart

Hi Garfus and welcome back, What a wonderful post. You are spot...

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hi Garfus and welcome back, What a wonderful post. You are spot...

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News